Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation

Annals of Epidemiology

Volumn 15, Issue 8, 2005, Pages 558-563

  Abbott, Kevin C ^a,b   Bernet, Victor J ^a,b   Agodoa, Lawrence Y ^c   Yuan, Christina M ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

African American; Complications; Cyclosporine; Diabetic Ketoacidosis; Female; Graft Loss; Hepatitis C; Hospitalization; Hyperglycemic Hyperosmolar Syndrome; Nonketotic Hyperosmolar Coma; Rejection; Tacrolimus; USRDS

Indexed keywords

TSUKUBAENOLIDE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONKETOTIC DIABETIC COMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SERODIAGNOSIS;

EID: 33644616507     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2004.10.003     Document Type: Article

References (26)

1. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, et al. Incidence and cost of new onset diabetes mellitus among US wait-listed and transplanted renal allograft recipients. Am J Transplant. 2003;3:590-598.
2. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3:178-185.
3. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol. 2002;13:1374-1380.
4. Abbott KC, Bernet VJ, Agodoa LY, Yuan CM. Diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome after renal transplantation in the United States. BMC Endocr Disord. 2003;3:1.
5. Petit JM, Bour JB, Galland-Jos C, Minello A, Verges B, Guiguet M, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol. 2001;35:279-283.
6. Sougleri M, Labropoulou-Karatza C, Paraskevopoulou P, Fragopanagou H, Alexandrides T. Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major. Eur J Gastroenterol Hepatol. 2001;13:1195-1199.
7. Garrido Serrano A, Guerrero Igea FJ, Lepe Jimenez JA, Palomo Gil S, Grilo Reina A. Hepatitis C virus infection, increased serum ferritin, and hyperinsulinemia. Rev Esp Enferm Dig. 2001;93:639-648.
8. Lonardo A, Loria P. Is insulin resistance a pathogenic co-factor in hepatitis C virus-related disease and hepatocellular carcinoma? Dig Liver Dis. 2002;34:151.
9. van Duijnhoven EM, Christiaans MH, Boots JM, Goossens VJ, Undre NA, van Hooff JP. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus. Am J Kidney Dis. 2002;40:195-201.
10. Cho YM, Park KS, Jung HS, Jeon HJ, Ahn C, Ha J, et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care. 2003;26:1123-1128.
11. Boots JM, van Duijnhoven EM, Christiaans MH, Wolffenbuttel BH, van Hooff JP. Glucose metabolism in renal transplant recipients on tacrolimus: The effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol. 2002;13:221-227.
12. Keshavarz R, Mousavi MA, Hassani C. Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant. Pediatr Emerg Care. 2002;18:22-24.
13. Toyonaga T, Kondo T, Miyamura N, Sekigami T, Sonoda K, Kodama S, et al. Sudden onset of diabetes with ketoacidosis in a patient treated with FK506/tacrolimus. Diabetes Res Clin Pract. 2002;56:13-18.
14. Ersoy A, Ersoy C, Tekce H, Yavascaoglu I, Dilek K. Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus. Transplant Proc. 2004;36:1407-1410.
15. Duijnhoven EM, Boots JM, Christiaans MH, Wolffenbuttel BH, Van Hooff JP. Influence of tacrolimus on glucose metabolism before and after renal transplantation: A prospective study. J Am Soc Nephrol. 2001;12: 583-588.
16. Hayakawa M, Gando S, Morimoto Y, Kemmotsu O. Development of severe diabetic keto-acidosis with shock after changing interferon-beta into interferon-alpha for chronic hepatitis C. Intensive Care Med. 2000;26:1008.
17. Bhatti A, McGarrity TJ, Gabbay R. Diabetic ketoacidosis induced by alpha interferon and ribavirin treatment in a patient with hepatitis C. Am J Gastroenterol. 2001;96:604-605.
18. Recasens M, Aguilera E, Ampurdanes S, Sanchez Tapias JM, Simo O, Casamitjana R, et al. Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med. 2001;18:764-767.
19. Mofredj A, Howaizi M, Grasset D, Licht H, Loison S, Devergie B, et al. Diabetes mellitus during interferon therapy for chronic viral hepatitis. Dig Dis Sci. 2002;47:1649-1654.
20. Jabr FI, Ordinario MM. Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am J Med. 2003;115:158-159.
21. Gentil MA, Lopez M, Gonzalez-Roncero F, Rodriguez-Algarra G, Pereira P, Lopez R, et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: Influence of new immunosuppression protocols. Transplant Proc. 2003;35:1748-1750.
22. Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis. 2003;42:1058-1068.
23. [No authors listed] Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2003; 26:5S-20S. Available at: http://care.diabetesjournals.org/cgi/content/full/26/suppl_1/s5?maxtoshow= &HITS= 10&hits=10&RESULTFORMAT= &searchid= 1071177483289_5859&stored_search=&FIRSTINDEX=0& minscore= 5000&journalcode=diacare. Accessed December 18, 2004.
24. Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: Clinical and biochemical differences. Arch Intern Med. 2004;164: 1925-1931.
25. Lemieux I, Houde I, Pascot A, Lachance JG, Noel R, Radeau T, et al. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney Int. 2002;62:1839-1847.
26. Baid S, Cosimi AB, Farrell ML, Schoenfeld DA, Feng S, Chung RT, et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation. 2001;72:1066-1072.